98 related articles for article (PubMed ID: 14728822)
21. Topical application of AT1 receptor antagonists prevents medial and neointimal proliferation after balloon injury.
Taguchi J; Abe J; Ohno M; Schwartz SM; Kurokawa K
Blood Press Suppl; 1994; 5():38-42. PubMed ID: 7889199
[TBL] [Abstract][Full Text] [Related]
22. Activation of apoptosis signal-regulating kinase 1 in injured artery and its critical role in neointimal hyperplasia.
Izumi Y; Kim S; Yoshiyama M; Izumiya Y; Yoshida K; Matsuzawa A; Koyama H; Nishizawa Y; Ichijo H; Yoshikawa J; Iwao H
Circulation; 2003 Dec; 108(22):2812-8. PubMed ID: 14638553
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
Kagawa T; Takao T; Horino T; Matsumoto R; Inoue K; Morita T; Hashimoto K
Nephrology (Carlton); 2008 Jun; 13(4):309-15. PubMed ID: 18331441
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II receptor blocker improves tumor necrosis factor-α-induced cytotoxicity via antioxidative effect in human glomerular endothelial cells.
Izawa-Ishizawa Y; Ishizawa K; Sakurada T; Imanishi M; Miyamoto L; Fujii S; Taira H; Kihira Y; Ikeda Y; Hamano S; Tomita S; Tsuchiya K; Tamaki T
Pharmacology; 2012; 90(5-6):324-31. PubMed ID: 23052181
[TBL] [Abstract][Full Text] [Related]
25. Loss-of-function deletion of the steroid receptor coactivator-1 gene in mice reduces estrogen effect on the vascular injury response.
Yuan Y; Xu J
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1521-7. PubMed ID: 17446438
[TBL] [Abstract][Full Text] [Related]
26. Olmesartan ameliorates insulin sensitivity by modulating tumor necrosis factor-alpha and cyclic AMP in skeletal muscle.
Yamaguchi K; Ura N; Murakami H; Togashi N; Hyakukoku M; Higashiura K; Shimamoto K
Hypertens Res; 2005 Sep; 28(9):773-8. PubMed ID: 16419651
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II Type 2 Receptor Inhibits Vascular Intimal Proliferation With Activation of PPARγ.
Kukida M; Mogi M; Ohshima K; Nakaoka H; Iwanami J; Kanno H; Tsukuda K; Chisaka T; Min LJ; Wang XL; Bai HY; Shan BS; Higaki A; Yamauchi T; Okura T; Higaki J; Horiuchi M
Am J Hypertens; 2016 Jun; 29(6):727-36. PubMed ID: 26471325
[TBL] [Abstract][Full Text] [Related]
28. Aging exacerbates neointimal formation, and increases proliferation and reduces susceptibility to apoptosis of vascular smooth muscle cells in mice.
Vazquez-Padron RI; Lasko D; Li S; Louis L; Pestana IA; Pang M; Liotta C; Fornoni A; Aitouche A; Pham SM
J Vasc Surg; 2004 Dec; 40(6):1199-207. PubMed ID: 15622375
[TBL] [Abstract][Full Text] [Related]
29. Stretch-induced activation of the transcription factor activator protein-1 controls monocyte chemoattractant protein-1 expression during arteriogenesis.
Demicheva E; Hecker M; Korff T
Circ Res; 2008 Aug; 103(5):477-84. PubMed ID: 18669921
[TBL] [Abstract][Full Text] [Related]
30. C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice.
Shagdarsuren E; Bidzhekov K; Mause SF; Simsekyilmaz S; Polakowski T; Hawlisch H; Gessner JE; Zernecke A; Weber C
Circulation; 2010 Sep; 122(10):1026-36. PubMed ID: 20733098
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cells.
Ohtani K; Egashira K; Ihara Y; Nakano K; Funakoshi K; Zhao G; Sata M; Sunagawa K
Hypertension; 2006 Oct; 48(4):664-70. PubMed ID: 16940231
[TBL] [Abstract][Full Text] [Related]
32. Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury.
Lv L; Zhang J; Wang P; Meng Q; Liang W; Zhang L
J Vasc Surg; 2014 Feb; 59(2):500-9. PubMed ID: 23755975
[TBL] [Abstract][Full Text] [Related]
33. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
Wang CH; Verma S; Hsieh IC; Hung A; Cheng TT; Wang SY; Liu YC; Stanford WL; Weisel RD; Li RK; Cherng WJ
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):540-7. PubMed ID: 17204664
[TBL] [Abstract][Full Text] [Related]
34. Hepatocyte gp130 deficiency reduces vascular remodeling after carotid artery ligation.
Salguero G; Schuett H; Jagielska J; Schley R; Tallone E; Luchtefeld M; Drexler H; Müller W; Grote K; Schieffer B
Hypertension; 2009 Nov; 54(5):1035-42. PubMed ID: 19805641
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress.
Tsuda M; Iwai M; Li JM; Li HS; Min LJ; Ide A; Okumura M; Suzuki J; Mogi M; Suzuki H; Horiuchi M
Hypertension; 2005 Apr; 45(4):545-51. PubMed ID: 15723967
[TBL] [Abstract][Full Text] [Related]
36. Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model.
Shi B; Long X; Zhao R; Liu Z; Wang D; Xu G
Exp Biol Med (Maywood); 2014 Mar; 239(3):356-65. PubMed ID: 24477823
[TBL] [Abstract][Full Text] [Related]
37. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model.
Lee S; Lim HJ; Park HY; Lee KS; Park JH; Jang Y
Atherosclerosis; 2006 May; 186(1):29-37. PubMed ID: 16098530
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of MCP-1/CCR2 signaling pathway is involved in synergistic inhibitory effects of irbesartan with rosuvastatin on vascular remodeling.
Ohshima K; Mogi M; Nakaoka H; Jing F; Iwanami J; Min LJ; Tsukuda K; Kanno H; Ogimoto A; Higaki J; Horiuchi M
J Am Soc Hypertens; 2012; 6(6):375-84. PubMed ID: 23107893
[TBL] [Abstract][Full Text] [Related]
39. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
40. Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation.
Karki R; Kim SB; Kim DW
Exp Cell Res; 2013 Dec; 319(20):3238-50. PubMed ID: 23906924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
